Graft-vs-host disease (GVHD) is a serious complication after allogeneic hematopoietic stem
cell transplantation causing significant morbidity and transplant-associated mortality. Acute …

Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Graft-versus-host disease (GVHD) continues to be a major complication following allogeneic
hematopoietic cell transplantation (allo-HCT) with high morbidity and mortality …

Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

Over the last decades significant advances have been made in the field of donor selection,
alternative transplant sources, immunosuppressive treatment and supportive care, as well …

Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …